ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma, Inc. (ABVC) Stock Price & Analysis

21 Followers

ABVC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.50 - $2.10
Previous Close$0.68
Volume7.68K
Average Volume (3M)34.87K
Market Cap
$22.53M
Enterprise Value$25.93M
Total Cash (Recent Filing)$1.87M
Total Debt (Recent Filing)$5.21M
Price to Earnings (P/E)-1.8
Beta1.18
Nov 13, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding33,080,740
10 Day Avg. Volume31,547
30 Day Avg. Volume34,873
Standard Deviation0.20
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)175.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.18
Enterprise Value/Gross Profit37.94
Enterprise Value/Ebitda-2.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ABVC FAQ

What was ABVC BioPharma, Inc.’s price range in the past 12 months?
ABVC BioPharma, Inc. lowest stock price was $0.50 and its highest was $2.10 in the past 12 months.
    What is ABVC BioPharma, Inc.’s market cap?
    Currently, no data Available
    When is ABVC BioPharma, Inc.’s upcoming earnings report date?
    ABVC BioPharma, Inc.’s upcoming earnings report date is Nov 13, 2023 which is in 164 days.
      How were ABVC BioPharma, Inc.’s earnings last quarter?
      Currently, no data Available
      Is ABVC BioPharma, Inc. overvalued?
      According to Wall Street analysts ABVC BioPharma, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does ABVC BioPharma, Inc. pay dividends?
        ABVC BioPharma, Inc. does not currently pay dividends.
        What is ABVC BioPharma, Inc.’s EPS estimate?
        ABVC BioPharma, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does ABVC BioPharma, Inc. have?
        ABVC BioPharma, Inc. has 33,080,740 shares outstanding.
          What happened to ABVC BioPharma, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of ABVC BioPharma, Inc.?
          Currently, no hedge funds are holding shares in ABVC

          ---

          ABVC BioPharma, Inc. Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -66.86%
          12-Months-Change

          Fundamentals

          Return on Equity
          -199.90%
          Trailing 12-Months
          Asset Growth
          -15.85%
          Trailing 12-Months
          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          ABVC BioPharma, Inc.

          American BriVision (Holding) Corp. is a clinical stage biopharmaceutical company, which focuses on the development of new drugs and medical devices. The company also integrates research achievements from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. It conducts clinical trials of translational medicine for Proof of Concept and out-licenses it to international pharmaceutical companies. Its products include BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia. The company was founded in 1990 and is headquartered in Fremont, CA.

          ---

          Top 5 ETFs holding ABVC

          Name
          Market Value
          Smart Score
          Vanguard Total Stock Market ETF
          $251.42K
          8
          Up to five ETFs with an Outperform Smart Score that hold ABVC. The ETFs are listed according to market value of ABVC within the ETF

          ---

          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Company
          Price & Change
          Follow
          Actinium Pharmaceuticals
          Aurinia Pharmaceuticals
          Brainstorm Cell Therapeutics
          Bio-Path Holdings

          Popular Stocks

          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis